6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Developmental effects of maternal smoking during pregnancy on the human frontal cortex transcriptome

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cigarette smoking during pregnancy is a major public health concern. While there are well-described consequences in early child development, there is very little known about the effects of maternal smoking on human cortical biology during prenatal life. We therefore performed a genome-wide differential gene expression analysis using RNA sequencing (RNA-seq) on prenatal (N=33; 16 smoking-exposed) as well as adult (N=207; 57 active smokers) human post-mortem prefrontal cortices. Smoking exposure during the prenatal period was directly associated with differential expression of 14 genes; in contrast, during adulthood, despite a much larger sample size, only 2 genes showed significant differential expression (FDR<10%). Moreover, 1,315 genes showed significantly different exposure effects between maternal smoking during pregnancy and direct exposure in adulthood (FDR<10%) – these differences were largely driven by prenatal differences that were enriched for pathways previously implicated in addiction and synaptic function. Furthermore, prenatal and age-dependent differentially expressed genes were enriched for genes implicated in non-syndromic autism spectrum disorder (ASD) and were differentially expressed as a set between patients with ASD and controls in post-mortem cortical regions. These results underscore the enhanced sensitivity to the biological effect of smoking exposure in the developing brain and offer insight into how maternal smoking during pregnancy affects gene expression in the prenatal human cortex. They also begin to address the relationship between in utero exposure to smoking and the heightened risks for the subsequent development of neuropsychiatric disorders.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: not found

          Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex

          DNA methylation (DNAm) is important in brain development, and potentially in schizophrenia. We characterized DNAm in prefrontal cortex from 335 non-psychiatric controls across the lifespan and 191 patients with schizophrenia, and identified widespread changes in the transition from prenatal to postnatal life. These DNAm changes manifest in the transcriptome, correlate strongly with a shifting cellular landscape, and overlap regions of genetic risk for schizophrenia. A quarter of published GWAS-suggestive loci (4,208/15,930, p<10−100) manifest as significant methylation quantitative trait loci (meQTLs), including 59.6% of GWAS-positive schizophrenia loci. We identified 2,104 CpGs that differ between schizophrenia patients and controls, enriched for genes related to development and neurodifferentiation. The schizophrenia-associated CpGs strongly correlate with changes related to the prenatal-postnatal transition and show slight enrichment for GWAS risk loci, while not corresponding to CpGs differentiating adolescence from later adult life. These data implicate an epigenetic component to the developmental origins of this disorder.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders.

            Recent advances in genetics and genomics have unveiled numerous cases of autism spectrum disorders (ASDs) associated with rare, causal genetic variations. These findings support a novel view of ASDs in which many independent, individually rare genetic variants, each associated with a very high relative risk, together explain a large proportion of ASDs. Although these rare variants impact diverse pathways, there is accumulating evidence that synaptic pathways, including those involving synaptic cell adhesion, are disrupted in some subjects with ASD. These findings provide insights into the pathogenesis of ASDs and enable the development of model systems with construct validity for specific causes of ASDs. In several neurodevelopmental disorders frequently associated with ASD, including fragile X syndrome, Rett syndrome and tuberous sclerosis, animal models have led to the development of new therapeutic approaches, giving rise to optimism with other causes of ASDs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.

              The activity-dependent transcription factor myocyte enhancer factor 2 (MEF2) induces excitatory synapse elimination in mouse neurons, which requires fragile X mental retardation protein (FMRP), an RNA-binding protein implicated in human cognitive dysfunction and autism. We report here that protocadherin 10 (Pcdh10), an autism-spectrum disorders gene, is necessary for this process. MEF2 and FMRP cooperatively regulate the expression of Pcdh10. Upon MEF2 activation, PSD-95 is ubiquitinated by the ubiquitin E3 ligase murine double minute 2 (Mdm2) and then binds to Pcdh10, which links it to the proteasome for degradation. Blockade of the Pcdh10-proteasome interaction inhibits MEF2-induced PSD-95 degradation and synapse elimination. In FMRP-lacking neurons, elevated protein levels of eukaryotic translation elongation factor 1 α (EF1α), an Mdm2-interacting protein and FMRP target mRNA, sequester Mdm2 and prevent MEF2-induced PSD-95 ubiquitination and synapse elimination. Together, our findings reveal roles for multiple autism-linked genes in activity-dependent synapse elimination. Copyright © 2012 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Journal
                9607835
                20545
                Mol Psychiatry
                Mol. Psychiatry
                Molecular psychiatry
                1359-4184
                1476-5578
                22 September 2018
                21 August 2018
                28 March 2019
                : 10.1038/s41380-018-0223-1
                Affiliations
                [1 ]Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA
                [2 ]Center for Computational Biology, Johns Hopkins University, Baltimore, MD, 21205, USA
                [3 ]Behavioral and Urban Health Program, Behavioral Health and Criminal Justice Division, RTI International, Research Triangle Park, NC, 27709, USA
                [4 ]The Lambert Center for the Study of Medicinal Cannabis and Hemp, Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, USA
                [5 ]Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
                [6 ]Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA
                [7 ]Fellow Program and Behavioral Health and Criminal Justice Division, RTI International, Research Triangle Park, NC, 27709, USA
                [8 ]Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
                [9 ]Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA
                [10 ]Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA
                [11 ]McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
                [12 ]Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA
                Author notes

                Author contributions:

                S.A.S – performed analyses and led the writing of the manuscript

                L.C. T. – performed analyses and contributed to the writing of the manuscript

                C.A.M, L.J.B., B.S.M., E.O.J. – contributed to the interpretation of the results and writing of the manuscript

                J.H.S. – performed data generation

                A.D. – performed clinical reviews and oversaw assessment of toxicology

                R.T. – performed RNA extractions

                M.H. – generated nicotine and cotinine data

                T.M.H. – performed tissue dissections, contributed to the study design, interpretation of the results, and writing of the manuscript

                D.R.W. – contributed to the study design, interpretation of the results, and writing of the manuscript

                D.B.H. – contributed to the study design, statistical analyses, interpretation of the results, and writing of the manuscript

                J.E.K., A.E.J – co-led the study, including the design, statistical analyses, interpretation, and writing of the manuscript

                [] Contact: joel.kleinman@ 123456libd.org Lieber Institute for Brain Development, 855 N Wolfe St, Ste 300. Baltimore MD 21205. Ph: 1-410-955-1000
                [* ] Contact: andrew.jaffe@ 123456libd.org Lieber Institute for Brain Development, 855 N Wolfe St, Ste 300. Baltimore MD 21205. Ph: 1-410-955-1000
                Article
                NIHMS976894
                10.1038/s41380-018-0223-1
                6438764
                30131587
                512657c3-ae04-43e4-ae9c-d2b12e8d3f8a

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article